Pamelor – See Related Topics

Just over half a century ago, Pamelor was developed and approved by the FDA (U.S Food and Drug Administration) for the treatment of depression. It is a TCA (tricyclic antidepressant) drug that is also known as nortriptyline when sold in a generic form. Since its approval in 1964, medical providers have consistently prescribed it mainly for the treatment of ADHD (Attention-Deficit Hyperactivity Disorder) where components of that disorder such as hyperactivity and impulsivity have experience the best results. Another primary reason for prescribing Pamelor is the off-label use in the treatment of post-herpetic neuralgia (pain associated with shingles).

Pamelor increases two key neurotransmitters in the brain (serotonin and norepinephrine) which help regulate mood for the user. It is a stimulant drug that is safe and considered to be non-addictive on a physical basis. While considered safe, it is not risk-free. The FDA has approved Pamelor only for individuals 18 years and older, though providers have prescribed it to younger individuals. That group is at a higher risk of developing suicidal thoughts when taking Pamelor, so medical supervision is a must. Dependency on this drug can happen – from a psychological standpoint. It is known to have strong side effects during tapering or if suddenly stopped. As such, some people continue to use it for longer than they should, as they are reluctant to experience the unpleasant side effects associated with withdrawing from the medication.

Reliance on Pamelor or any TCA drug is an issue and discontinuation without medical supervision can be problematic – but help is available. To learn more, check out the related topics provided or contact a representative at The Recovery Village to learn about your options.